Pages that link to "Q114529746"
Jump to navigation
Jump to search
The following pages link to John Anastasi (Q114529746):
Displaying 9 items.
- Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. (Q33380148) (← links)
- The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q). (Q33822153) (← links)
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. (Q35080478) (← links)
- Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature (Q35887901) (← links)
- Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720. (Q44083625) (← links)
- RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. (Q52643951) (← links)
- Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. (Q54985734) (← links)
- Therapy-Related Myelodysplastic Syndrome (Q59315417) (← links)
- Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461 (Q59315424) (← links)